Psychosocial interventions for cocaine and psychostimulant amphetamines related disorders

Cochrane Database of Systematic Reviews

Volumn , Issue 3, 2007, Pages

  Knapp, Werner Paulo ^a   Soares, B ^b   Farrel, M ^b   Lima, M S ^b  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b NONE

Author keywords

Adaptation, psychological; Amphetamine related disorders psychology; *therapy ; Cocaine related disorders psychology; *therapy ; Cognitive therapy methods ; Counseling methods ; Psychotherapy *methods

Indexed keywords

AMPHETAMINE DERIVATIVE; COCAINE;

ABSTINENCE; AGGRESSION; CLINICAL FEATURE; COCAINE DEPENDENCE; COCHRANE LIBRARY; COGNITIVE THERAPY; DRUG DEPENDENCE; EMBASE; GROUP THERAPY; HUMAN; MEDICAL LITERATURE; OUTCOME ASSESSMENT; PARANOIA; PATIENT COMPLIANCE; PATIENT COUNSELING; PSYCHOSOCIAL CARE; PUBLICATION; REINFORCEMENT; REVIEW; STEREOTYPY; SYMPTOM; TREATMENT OUTCOME;

EID: 41549148459     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD003023.pub2     Document Type: Review

References (81)

1. Baker 2001 {published data only} *Baker A, Boggs TG, Lewin TJ. Randomized controlled trial of brief cognitive-behavioural interventions among regular users of amphetamine. Addiction 2001;96:1279-87.
2. Carroll 1991 {published data only} *Carrol KM, Rounsaville BJ, Gawin FH. A Comparative Trial of Psychotherapies for Ambulatory Cocaine Abusers: Relapse Prevention and Interpersonal Psychotherapy. American Jurnal of Dug and Alcohol Abuse 1991;17(3):229-47.
3. Carroll 1994 {published data only} Carrol KM, Nich C, Rounsaville BJ. Differential symptom reduction in depressed cocaine abusers treated with psychotherapy and pharmcotherapy. The Journal of Nervous and Mental disease 1995;183:251-9.
4. *Carroll KM, Rounsaville BJ, Gordon LT, et al.Psychotherapy and pharmacotherapy for ambulatory cocaine abusers. Archives of General Psychiatry 1994;51:177-87.
5. Carroll KM, Rounsaville BJ, Nich C, et al.One-year follow-up of psychotherapy and pharmacotherapy fo cocaine dependence: delayed emergence of psychotherapy effects. Archives of General Psychiatry 1994;51:989-97.
6. Carroll 1998 {published data only} *Carroll KM, Nich C, Ball SA, McCance E, Frankforter TL, Rounsaville BJ. One-year follow-up of disulfiram and psychotherapy for cocaine-alcohol users: sustained effects of treatment. Addiction 2000;95(9):1335-49.
7. Carroll KM, Nich C, Ball SA, McCance E, Rounsavile BJ. Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram. Addiction 1998;93(5):713-28.
8. Crits-Christoph 1999 {published data only} Barber JP, Foltz C, Crits-Christoph P, Chittams J. Therapists' adherence and competence and treatment discrimination in the NIDA Collaborative Cocaine Treatment Study. J Clin Psychol 2004;60(1):29-41.
9. Crits-Christoph P, Siqueland L, Blaine J, Frank A, Luborsky L, Onken LS, et al.The National Institute on Drug Abuse Collaborative Cocaine Treatment Study: rationale and methods. Archives of General Psychiatry 1997;54:721-6.
10. *Crits-Christoph P, Siqueland L, Blaine J, Frank A, Luborsky L, Onken LS, et al.Psychosocial treatments for cocaine dependence: National Institute of Drug Abuse Collaborative Cocaine Treatment Study. Arch Gen Psychiatry 1999;56:493-502.
11. Weiss RD, Griffin ML, Gallop RJ, Najavits LM, Frank A, Crits-Christoph P, et al.The effect of 12-step self-help group attendance and participation on drug use outcomes among cocaine-dependent patients. Drug Alcohol Depend 2005;77(2):177-84.
12. Gottheil 1998 {published data only} *Gottheil E, Weinstein SP, Sterling RC, Lundy A, Serota RD. A randomized controlled study of the effectiveness of intensive outpatient treatment for cocaine dependence. Psychiatric Services 1998;49(6):782-7.
13. Weinstein SP, Gottheil E, Sterling RC. Randomized comparison of intensive outpatient vs individual therapy for cocaine abusers. Journal of Addictive Disorders 1997;16:41-56.
14. Hall 1994 {published data only} *Hall SM, Tunis S, Triffleman E, Banys P, Clark HW, Tusel D, et al.Continuity of Care and Desipramine in Primary Cocaine Abusers. The Journal of Nervous and Mental Disease 1994;182(10):570-5.
15. Higgins 1993 {published data only} Higgins ST, Budney AJ, Bickel WK, Badger GJ, Foerg FE, Ogden D. Outpatient Behavioral Treatment for Cocaine Dependence One-Year Outcome. Experimental and Clinical Psychopharmacology 1995;3(2):205-12.
16. *Higgins ST, Budney AJ, Bickel WK, Hughes JR, Foerg FE, Badger GJ. Achieving Cocaine Abstinence With a Behavioral Approach. American Journal of Psychiatry 1993;150(5):763-9.
17. Higgins 1994 {published data only} Higgins ST, Budney AJ, Bickel WK, Badger GJ, Foerg FE, Ogden D. Outpatient Behavioral Treatment for Cocaine Dependence. One-Year Outcome. Experimental and Clinical Psychopharmacology 1995;3(2):205-12.
18. *Higgins ST, Budney AJ, Bickel WK, Foerg FE, Donham R, Badger GJ. Incentives Improve Outcome in Outpatient Behavioral treatment of Cocaine Dependence. Archives of General Psychiatry 1994;51(July):568-76.
19. Higgins 2000 {published data only} *Higgins ST, Wong CJ, Badger GJ, Ogden DEH, Dantona RL. Contingent Reinforcement Increases Cocaine Abstinence During Outpatient Treatment and 1 Year of Follow-Up. Journal of Consulting and Clinical Psychology 2000;68(1):64-72.
20. Higgins 2003 {published data only} *Higgins ST, Sigmon SC, Wong CJ, Heil SH, Badger GJ, Donham R, et al.Community reinforcement therapy for cocaine-dependent outpatients. Archives of General Psychiatry 2003;60(10):1043-52.
21. Hoffman 1994 {published data only} *Hoffman JA, Caudill BD, Koman JJ, Luckey JW, Flynn PM, Hubbard RL. Comparative Cocaine Abuse Treatment Strategies: Enhancing Client Retention and Treatment Exposure. Journal of Addictive Diseases 1994;13(4):115-28.
22. Hoffman JA, Caudill BD, Koman JJ, Luckey JW, Flynn PM, Mayo DW. Psychosocial Treatments for Cocaine Abuse. 12-Month treatment Outcomes. Journal of Substance Abuse Treatment 1996;13(1):3-11.
23. Jones 2005 {published data only} *Jones HE, Wong CJ, Tuten M, Stitzer ML. Reinforcement-based therapy: 12-month evaluation of an outpatient drug-free treatment for heroin abusers. Drug Alcohol Depend 2005;79(2):119-28.
24. Kirby 1998a {published data only} *Kirby KC, Marlowe DB, Lamb RJ, Platt JJ. Schedule of Voucher Delivery Influences Initiation of Cocaine Abstinence. Journal of Consulting and Clinical Psychology 1998;66(5):761-7.
25. Kirby 1998b {published data only} *Kirby KC, Marlowe DB, Festinger DS, Lamb RJ, Platt JJ. Schedule of Voucher Delivery Influences Initiation of Cocaine Abstinence. Journal of Consulting and Clinical Psychology 1998;66(5):761-7.
26. Magura 1994 {published data only} *Magura S, Rosenblum A, Lovejoy M, Handelsman L, Foote J, Stimmel B. Neurobehavioral Treatment for Cocaine-Using Methadone Patients: A Preliminary Report. Journal of Addictive Diseases 1994;13(4):143-60.
27. Maude-Griffin 1998 {published data only} *Maude-Griffin PM, Hohenstein JM, Humfleet GL, Reilly PM, Tusel DJ, Hall SM. Superior Efficacy of Cognitive-Behavioral Therapy for Urban Crack Cocaine Abusers: Main and Matching Effects. Journal of Consulting and Clinical Psychology 1998;66(5):832-7.
28. McKay 1997 {published data only} McKay JR, Alterman AI, Cacciola JS, O'Brien CP, Koppenhaver JM, Shepard DS. Continuing Care for Cocaine Dependence Comprehensive 2-Year Outcomes. Journal of Consulting and Clinical Psychology 1999;67(3):420-7.
29. *McKay JR, Alterman AI, Cacciola JS, Rutherford MJ, O'Brien CP, Koppenhaver J. Group Counseling Versus Individualized Relapse Prevention Aftercare Following Intensive Outpatient Treatment for Cocaine Dependence: Initial Results. Journal of Consulting and Clinical Psychology 1997;65(5):778-88.
30. Monti 1997 {published data only} *Monti PM, Rohsenow DJ, Michalec E, Martin RA, Abrams DB. Brief coping skills treatment for cocaine abuse: substance use outcomes at three months. Addiction 1997;99(12):1717-28.
31. Rohsenow DJ, Monti PM, Martin RA, Michalec E, Abrams DB. Brief Coping Skills Treatment for Cocaine Abuse: 12-Month Substance Use Outcomes. Journal of Consulting and Clinical Psychology 2000;68(3):515-20.
32. Petry 2005 a {published data only} *Petry NM, Peirce JM, Stitzer ML, Blaine J, Roll JM, Cohen A, et al.Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study. Archives of General Psychiatry 2005;62(10):1148-56.
33. Petry 2005 b {published data only} *Petry NM, Martin B, Simcic F. Prize reinforcement contingency management for cocaine dependence: integration with group therapy in a methadone clinic. J Consult Clin Psychol 2005;73(2):354-9.
34. Rawson 2002 {published data only} Farabee D, Rawson R, McCann M. Adoption of drug avoidance activities among patients in contingency management and cognitive-behavioral treatments. J Subst Abuse Treat 2002;23(4):343-50.
35. *Rawson RA, Huber A, McCann M, Shoptaw S, Farabee D, Reiber C, et al.A comparison of contingency management and cognitive-behavioral approaches during methadone maintenance treatment for cocaine dependence. Arch Gen Psychiatry 2002;59(9):817-24.
36. Rosenblum 2005 {published data only} *Rosenblum A, Magura S, Kayman DJ, Fong C. Motivationally enhanced group counseling for substance users in a soup kitchen: a randomized clinical trial. Drug Alcohol Depend 2005;80(1):91-103.
37. Schmitz 1997 {published data only} *Schmitz JM, Oswald LM, Jacks SD, Rustin T, Rhoades HM, Grabowski J. Relapse Prevention Treatment for Cocaine Dependence: Group Vs Individual Format. Addictive Behaviors 1997;22(3):405-18.
38. Silverman 1996 {published data only} *Silverman K, Higgins ST, Brooner RK, Montoya ID, Cone EJ, Schuster CR, et al.Sustained Cocaine Abstinence in Methadone Maintenance patients Through Voucher-Based Reinforcement Therapy. Archives of General Psychiatry 1996;53(5):409-15.
39. Silverman 1998 {published data only} *Silverman K, Wong CJ, Umbricht-Schneiter A, Montoya ID, Schuster CR, Preston KL. Broad Beneficial Effects of Cocaine Abstinence Reinforcement Among Methadone Patients. Journal of Consulting and Clinical Psychology 1998;66(5):811-24.
40. Silverman 2001 {published data only} *Silverman K, Svikis D, Robles E, Stitzer ML, Bigelow GE. A Reinforcement-Based Therapeutic Workplace for the Treatment of Drug Abuse. Six-Month Abstinence Outcomes. Experimental and Clinical Psychopharmacology 2001;9(1):14-23.
41. Alim 1995 Alim TN, Rosse RB, Vocci FJ Jr, Lindquist T, Deutsch SI. Dethylpropion Pharmacotherapeutic Adjuvant Therapy for Inpatient Treatment of Cocaine Dependence: A Test of the Cocaine-Agonist Hypothesis. Clinical Neuropharmacology 1995;18(2):183-95.
42. Alterman 1996 Alterman AI, Snider EC, Cacciola JS, May DJ, Parikh G, Maany I, et al.A Quasi-Experimental Comparison of the Effectiveness of 6- versus 12-Hour per Week Outpatient Treatments for Cocaine Dependence. Journal of Nervous & Mental Disease 1996;184(1):54-6.
43. Azrin 1994 Azrin NH, McMahon PT, Donouhe B, Besalel VA, Lapinski KJ, Kogan ES, et al.Behavior Therapy for Drug Abuse: A Controlled Treatment Outcome Study. Behaviour Research & Therapy 1994;32(8):857-66.
44. Azrin 1996 Azrin NH, Acierno R, Kogan ES, Donouhe B, Besalel VA, McMahon PT. Follow-up results of Supportive versus Behavioral Therapy for illicit drug use. Behaviour Research & Therapy 1996;34(1):41- 6.
45. Brooner 1998 Brooner RK, Kidorf M, King VL, Stoller K. Preliminary evidence of good treatment response in antisocial drug abusers. Drug and Alcohol Dependence 1998;49:249-60.
46. Budney 1993 Budney AJ, Higgins ST, Bickel W, Kent L. Relationship between intravenous use and achieving initial cocaine abstinence. Drug and Alcohol Dependence 1993;32(2):133-42.
47. Carroll 1994b Carroll KM, Rounsaville BJ, Nich C, Gordon LT, Wirtz PW, Gawin F. One-Year Follow-up of Psychotherapy and Pharmacotherapy for Cocaine Dependence. Delayed Emergence of Psychotherapy Effects. Archives of General Psychiatry 1994;51(12):989-97.
48. Covi 2002 Covi L, Hess JM, Schroeder JR, Preston KL. A dose response study of cognitive behavioral therapy in cocaine abusers. J Subst Abuse Treatment 2002;23(3):191-7.
49. Crits-Christoph 1997 Crits-Christoph P, Siqueland L, Blaine J, Frank A, Luborsky L, Onken LS, et al.The National Institute on Drug Abuse Collaborative Cocaine treatment Study. rationale and Methods. Archives of General Psychiatry 1997;54(8):721-6.
50. Dansereau 1996 Dansereau DF, Joe GW, Dees SM, Simpson DD. Ethnicity and the Effects of Mapping-Enhance Drug Abuse Counseling. Addictive Behaviors 1996;21(3):363-76.
51. Dees 1997 Dees SM, Dansereau DF, Simpson DD. Mapping-Enhanced Drug Abuse Counseling: Urinalysis Results in the First Year of Methadone Treatment. Journal of Substance Abuse Treatment 1997;14(1):45-54.
52. Gawin 1984 Gawin FH, Kleber HD. Cocaine Abuse Treatment. Open Pilot Trial With Desipramine and Lithium Carbonate. Archives of General Psychiatry 1984;41(9):903-9.
53. Gawin 1989 Gawin FH, Kleber HD, Byck R, Rounsaville BJ, Kosten TR, Jatlow PI, et al.Desipramine Facilitation of Inicial Cocaine Abstinence. Archives of General Psychiatry 1989;46(2):117-21.
54. Hawkins 1989 *Hawkins DJ, Catalano RF, Gillmore MR, Wells EA. Skills Training for Drug Abusers: Generalization, Maintenance, and Effects on Drug Use. Journal of Consulting and Clinical Psychology 1989;57(4):559-63.
55. Kang 1991 Kang S-Y, Kleinman PH, Woody GE, Millman RB, Todd TC, Kemp J, et al.Outcomes for Cocaine Abusers After Once-a-Week Psychosocial Therapy. American Journal of Psychiatry 1991;148(5):630-5.
56. Keller 1999 Keller DS, Galanter M. Technology Transfer of Network Therapy to Community-Based Addictions Counselors. Journal of Substance Abuse Treatment 1999;16(2):183-9.
57. Knight 1994 Knight DK, Dansereau DF, Joe GW, Simpson DD. The Role of Node-Link Mapping in Individual and Group Counseling. American Journal of Drug and Alcohol Abuse 1994;20(4):517-27.
58. Kosten 1993 Kosten TA, Gawin FH, Kosten TR, Rounsaville BJ. Gender Differences in Cocaine Use and Treatment Response. Journal of Substance Abuse Treatment 1993;10(1):63-6.
59. Kouri 1995 Kouri EM, Lukas SE, Mendelson JH. P300 Assessment of Opiate and Cocaine Users: Effects of Detoxification and Buprenorphine Treatment. Biological Psychiatry 1996;40(7):617-28.
60. McKay 1998 McKay JR, McLellan T, Alterman AI, Cacciola JS, Rutherford MJ, O'Brien CP. Predictors of Participation in Aftercare Sessions and Self-Help Groups Following Completion of Intensive Outpatient Treatment for Substance Abuse. Journal of Studies on Alcohol 1998;59(2):152-62.
61. McKay 2005 McKay JR, Lynch KG, Shepard DS, Pettinati HM. The Effectiveness of Telephone-Based Continuing Care for Alcohol and Cocaine Dependence. Archives of General Psychiatry 2005;62:199-207.
62. Miller 1983 Miller L, Griffith J. A Comparison of Bupropion, Dextroamphetamine, and Placebo in Mixed-Substance Abusers. Psychopharmacology 1983;80(3):199-205.
63. Ollo 1996 Ollo C, Alim TN, Rosse RB, Lindquist T, Green T, Gillis T, et al.Lack of Neurotoxic Effect of Diethylpropion in Crack-Cocaine Abusers. Clinical Neuropharmacology 1996;19(1):52-8.
64. Saxon 1996 Saxon AJ, Wells EA, Fleming C, Jackson TR, Calsyn DA. pre-treatment characteristics, program philosophy and level of ancillary services as predictors of methadone maintenance treatment outcome. Addiction 1996;91(8):1197-209.
65. Siqueland 1998 Siqueland L, Crits-Christoph P, Frank A, Daley D, Weiss R, Chittams J, et al.Predictors of dropout from psychosocial treatment of cocaine dependence. Drug and Alcohol Dependence 1998;52(1):1-13.
66. Weddington 1991 Weddington WW, Brown BS, Haertzen CA, Hess JM, Mahaffey JR, Kolar AF, et al.Comparison of Amantadine and Desipramine Combined with Psychotherapy for Treatment of Cocaine Dependence. American Journal of Drug and Alcohol Abuse 1991;17(2):137-52.
67. Weinstein 1997 Weinstein SP, Gottheil E, Sterling RC. Randomized Comparison of Intensive Outpatient vs. Individual Therapy for Cocaine Abusers. Journal of Addictive Diseases 1997;16(2):41-56.
68. Weiss 1996 Weiss Rd, Griffin ML, Najavits LM, Hufford C, Kogan J, Thompson HJ, et al.Self-help activities in cocaine dependent patients entering treatment: results from the NIDA collaborative cocaine treatment study. Drug and Alcohol Dependence 1996;43(1-2):79-86.
69. Wells 1994 Wells EA, Peterson PL, Gainey RR, Hawkins JD, Catalano RF. Outpatient treatment for cocaine abuse: a controlled comparison of relapse prevention and twelve-step approaches. American Journal of Drug and Alcohol Abuse 1994;20(1):1-17.
70. Winters 2000 *Winters KC, Stinchfield RD, Opland E, Weller C, Latimer WW. The effectiveness of the Minnesota Model approach in the treatment of adolescent drug abusers. Addiction 2000;95(4):601-12.
71. Richard 1995
72. Rosemblum 1999
73. Annis 1990 Annis HM. Relapse to substance abuse: Empirical findings within a cognitive-social learning approach. Journal of Psychoactive Drugs 1990;22:117-24.
74. Carroll 1991b Carroll KM, Rounsaville BJ, Gawin FH. A comparative trial of psychotherapies for ambulatory cocaine abusers: relapse prevention and interpersonal psychotherapy. Am J Drug Alcohol Abuse 1991;17:229- 47.
75. Getter 1992 Getter H, Litt MD, Kadden RM, Cooney NL. Measuring treatment process in coping skills and interactional group therapies for alcoholism. International Journal of Group Psychotherapy 1992;42:419-29.
76. Green 2007 Green S, Higgins J, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.X [updated month year]. http://www.cochrane.dk/cochrane/handbook/handbook.htm [(accessed day month year).
77. King 1997 King GR, Ellinwood EH. Amphetamines and other stimulants. In: LowinsonJH, RuizP, MillmanRB, LangrodJG editor(s). Substance abuse - a comprehensive textbook. Third Edition. Baltimore: Williams & Wilkins, 1997:207-23.
78. Klein 1998 Klein M. Research Issues Related to Development of Medications for Treatment of Cocaine Addiction. Annals of the New York Academy of Sciences 1998;844:75-91.
79. Lowinson 1997 Lowinson JH, Ruiz P, Millman RB, Langrod JG. Substance Abuse - a comprehensive textbook. Third Edition. Baltimore: Williams & Wilkins, 1997.
80. Marlatt 1985 Marlatt GA, Gordon JR. Relapse Prevention. New York: Guilford Press, 1985.
81. Schulz 1995 Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273:408-12.